Funder
National Key R&D Program of China
Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences
Beijing Hope Run Special Fund of Cancer Foundation of China
Subject
Pharmacology,General Medicine
Reference23 articles.
1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int. J. Cancer,2015
2. Cancer statistics, 2018;Siegel;CA Cancer J. Clin.,2018
3. Hepatocellular carcinoma: a global view;Yang;Nat. Rev. Gastroenterol. Hepatol.,2010
4. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial;Bruix;Lancet,2017
5. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol.,2009
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献